ML323
Product Specifications
Background
Potent and reversible USP1-UAF1 deubiquitinase complex inhibitor with excellent selectivity against human DUBs, deSUMOylase, deneddylase and unrelated proteases, IC50=76 nm in a ubiquitin-rhodamine 110 assay.1 In H1299 non-small cell lung cancer cells treatment with ML323 dose dependently and robustly increased levels of monoubiquitinated PCNA compared to untreated cells at concentrations as low as 1 M.1 It potentiates cisplatin cytotoxicity in non-small cell lung cancer and osteosarcoma cells.2 ML323 inhibition of upregulated USP1 in BRCA1-deficient tumor cells results in replication fork destabilization and decreased viability.3
Conjugation
Unconjugated
Buffer
White solid
Storage Conditions
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-62691R-PerCP-Cy5.5 100 µL
PCTAIRE1 Recombinant Antibody, PerCP-Cy5.5 Conjugated
Sign In for Pricing
View Details 
TRV-0031025 96 Tests
Multiplex Assay Kit for Lysophosphatidylcholine Acyltransferase 1 (LPCAT1), etc. by FLIA (Flow Luminescence Immunoassay)
Sign In for Pricing
View Details